Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers : A Review
Joint Authors
Bougie, O.
Weberpals, Johanne I.
Source
International Journal of Surgical Oncology
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-08-08
Country of Publication
Egypt
No. of Pages
11
Main Subjects
Abstract EN
Individuals who carry an inherited mutation in the breast cancer 1 (BRCA1) and BRCA2 genes have a significant risk of developing breast and ovarian cancer over the course of their lifetime.
As a result, there are important considerations for the clinician in the counseling, followup and management of mutation carriers.
This review outlines salient aspects in the approach to patients at high risk of developing breast and ovarian cancer, including criteria for genetic testing, screening guidelines, surgical prophylaxis, and chemoprevention.
American Psychological Association (APA)
Bougie, O.& Weberpals, Johanne I.. 2011. Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers : A Review. International Journal of Surgical Oncology،Vol. 2011, no. 2011, pp.1-11.
https://search.emarefa.net/detail/BIM-466986
Modern Language Association (MLA)
Bougie, O.& Weberpals, Johanne I.. Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers : A Review. International Journal of Surgical Oncology No. 2011 (2011), pp.1-11.
https://search.emarefa.net/detail/BIM-466986
American Medical Association (AMA)
Bougie, O.& Weberpals, Johanne I.. Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers : A Review. International Journal of Surgical Oncology. 2011. Vol. 2011, no. 2011, pp.1-11.
https://search.emarefa.net/detail/BIM-466986
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-466986
